BridgeBio Pharma CEO Neil Kumar reports sale of $4.28 million in common shares

PUBT · 14h ago
BridgeBio Pharma CEO Neil Kumar reports sale of $4.28 million in common shares
  • BridgeBio Pharma CEO and director Neil Kumar sold 54,980 common shares on Nov. 18-19, 2026.
  • Direct sales totaled 34,980 shares, leaving 243,327 shares held directly.
  • The Kumar Haldea Family Irrevocable Trust sold 20,000 shares, reducing its holdings to 475,686 shares.
  • Reported weighted-average sale prices ranged from $76.9915 to $79.293 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001743881-26-000045), on November 20, 2026, and is solely responsible for the information contained therein.